P

PharmaCyte Biotech
D

PMCB

0.45320
USD
0.04
(8.42%)
Market Closed
Volume
1,844
EPS
-0
Div Yield
-
P/E
-0
Market Cap
4,865,396
Overview
Related Instruments
A
AKBA
D
Akebia Therapeutics
0.90970
0.00740(0.82%)
B
BCRX
D
BioCryst Pharmaceuticals
8.67000
-0.01500(-0.17%)
8.61000-0.06000(-0.69%)
E
EYPT
D
EyePoint Pharmaceuticals
3.84000
-0.15000(-3.76%)
3.87500+0.03500(+0.91%)
O
OGEN
D
Oragenics
0.49500
0.01190(2.46%)
S
SNDL
D
SNDL
1.38000
0.01500(1.10%)
V
VTVT
D
vTv Therapeutics
31.760
0.590(1.89%)
More
Articles
PMCB article featured image

What Is the DAX and How to Invest in It?

Learn what the DAX index is, how it works, which companies it includes, and how you can invest or trade it. A practical guide for retail investors and traders.

3 weeks ago
Trading Beginners
More

Title: PharmaCyte Biotech

Sector: Healthcare
Industry: Biotechnology
PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.